dc.contributor.author | Xiros, N. | en |
dc.contributor.author | Economopoulos, T. | en |
dc.contributor.author | Fountzilas, George | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Samantas, E. | en |
dc.contributor.author | Raptis, S. | en |
dc.creator | Xiros, N. | en |
dc.creator | Economopoulos, T. | en |
dc.creator | Fountzilas, George | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Samantas, E. | en |
dc.creator | Raptis, S. | en |
dc.date.accessioned | 2018-06-22T09:53:29Z | |
dc.date.available | 2018-06-22T09:53:29Z | |
dc.date.issued | 1999 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41862 | |
dc.language.iso | eng | en |
dc.source | Haematologica | en |
dc.subject | Cyclophosphamide | en |
dc.subject | Etoposide | en |
dc.subject | Human | en |
dc.subject | Prednisone | en |
dc.subject | Vincristine | en |
dc.subject | Humans | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Controlled study | en |
dc.subject | Female | en |
dc.subject | Middle aged | en |
dc.subject | Prognosis | en |
dc.subject | Recurrence | en |
dc.subject | Antineoplastic combined chemotherapy protocols | en |
dc.subject | Clinical article | en |
dc.subject | Clinical trial | en |
dc.subject | Controlled clinical trial | en |
dc.subject | Drug efficacy | en |
dc.subject | Phase 2 clinical trial | en |
dc.subject | Randomized controlled trial | en |
dc.subject | Idarubicin | en |
dc.subject | Mitoxantrone | en |
dc.subject | Nonhodgkin lymphoma | en |
dc.subject | Epirubicin | en |
dc.subject | Male | en |
dc.subject | Intravenous drug administration | en |
dc.subject | Lymphoma | en |
dc.subject | Blood toxicity | en |
dc.subject | Letter | en |
dc.subject | Oral drug administration | en |
dc.subject | Non-hodgkin | en |
dc.subject | Prednisolone | en |
dc.subject | Relapse | en |
dc.subject | Remission | en |
dc.title | A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non- Hodgkin's lymphoma [6] | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 84 | |
dc.description.issue | 2 | |
dc.description.startingpage | 189 | |
dc.description.endingpage | 190 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |